Rankings
▼
Calendar
OCGN FY 2022 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$578M
FY 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
100.0% margin
Operating Income
-$89M
-3580.0% margin
Net Income
-$87M
-3488.9% margin
EPS (Diluted)
$-0.40
Cash Flow
Operating Cash Flow
-$60M
Free Cash Flow
-$65M
Stock-Based Comp.
$11M
Balance Sheet
Total Assets
$109M
Total Liabilities
$35M
Stockholders' Equity
$74M
Cash & Equivalents
$78M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$2M
$0
—
Operating Income
-$89M
-$58M
-53.5%
Net Income
-$87M
-$58M
-48.7%
← Q4 2021
All Quarters
Q1 2022 →